Nemes Rush Group LLC Raises Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Nemes Rush Group LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 256.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 849 shares of the company’s stock after acquiring an additional 611 shares during the period. Nemes Rush Group LLC’s holdings in GE HealthCare Technologies were worth $66,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in GEHC. CoreFirst Bank & Trust bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $25,000. Continuum Advisory LLC lifted its position in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the period. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $28,000. Bank of Jackson Hole Trust purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth about $32,000. Finally, Flagship Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $34,000. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on GEHC shares. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup upped their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $97.73.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $79.36 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market capitalization of $36.29 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 3.19 and a beta of 1.13. The stock has a 50-day moving average of $86.30 and a 200 day moving average of $85.71. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.18%. GE HealthCare Technologies’s payout ratio is 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.